Thromboembolic complications in COVID-19 disease, a brief update

The role of coagulopathy in severe novel coronavirus infection remains to be clarified. Coagulopathy mechanisms can summarised two main pathways: inflammation-related and specific-virus related pathways. incidence thromboembolic events is high with pulmonary embolism being the most frequent complication. Low molecular weight heparin considered prophylactic therapeutic option patients COVID-19. Treatment complications should started without delay all cases certain or clinically suspected diagnosis, whether confirmed not specific diagnostic methods. article reviews following: development COVID-19 including those directly action virus, value biochemical markers thromboelastography, events, approaches prevention treatment COVID-19-associated coagulopathy.